Bioactive Collagen Peptides in Veterinary and Biomedical Science—Part II: The Gut–Collagen Peptide Axis, Bile Acid Signaling, and Translational Therapeutic Applications

Le résumé fourni par la source

Bioactive collagen peptides and collagen hydrolysates are dietary proteins whose degradation products also carry signaling activity. This second part of a two-part narrative review addresses the translational dimensions of their bioactivity, integrating veterinary clinical trials, controlled animal-model studies, and human biomedical data, with evidence strictly stratified by type. The gastrointestinal tract acts not only as the absorption site but as a target organ. In cell culture and rodent models, luminal collagen fragments restore tight-junction integrity, alter the microbiome, and shift the enterohepatic bile acid pool; increased secondary bile acid synthesis is proposed to engage the farnesoid X receptor (FXR) and Takeda G-protein-coupled receptor 5 (TGR5). None of these steps have been demonstrated in veterinary clinical patients. The accompanying GLP-1 and PYY response may reflect direct amino acid stimulation of enteroendocrine cells as much as a bile acid-dependent route, and current data do not separate the two. Veterinary trials show objective kinetic improvement in osteoarthritic dogs and horses. Taurine-responsive dilated cardiomyopathy is a reversible, diet-amenable condition; as the principal bile acid conjugation substrate in carnivores, taurine acts on the same bile acid pool as a mechanistically separate input. Recent data implicate prolyl-hydroxyproline in brown adipogenesis, collagen peptides in hippocampal neurogenesis, and taurine in platelet normalisation. The gut-collagen peptide axis is an evolving model linking dietary collagen to systemic metabolic, endocrine, and immune signaling, with implications for companion-animal, equine, and livestock practice.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.